MENLEY & JAMES INC
10-Q/A, 1996-10-01
PHARMACEUTICAL PREPARATIONS
Previous: PHYCOR INC/TN, 424B5, 1996-10-01
Next: CARGILL FINANCIAL SERVICES CORP, 8-K, 1996-10-01



Menley & James, Inc.
100 Tournament Drive
Horsham, PA 19044

October 1, 1996

Securities and Exchange Commission
450 5th Street, N.W.
Judiciary Plaza
Washington, D.C. 20549

Ladies and Gentlemen:

     Pursuant to regulations of the Securities and Exchange Commission,
submitted herewith on behalf of Menley & James, Inc. (the "Company") is 
Amendment number 1 to the Company's Quarterly Report on Form 10-Q for
the fiscal quarter ended June 30, 1996.  This Amendment includes Exhibit
number 27 - Financial Data Schedule, which is submitted electronically
for information only and not filed.

  This information is being submitted by direct transmission to the 
Commission's EDGAR System.

Sincerely,


William W. Yeager
Chief Financial Officer


                             SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the 
registrant has duly caused this report to be signed on its behalf by the 
undersigned thereunto duly authorized.

                                              MENLEY & JAMES, INC.

                                              William W. Yeager

                                              William W. Yeager
                                                Chief Financial Officer
                                                  (and duly authorized
                                                   officer of the registrant)

Date:  October 1, 1996

<TABLE> <S> <C>
                                               
<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the
Condensed Consolidated Balance Sheet at June 30, 1996 (unaudited) and the
Condensed Consolidated Statement of Operations for the Six Months Ended 
June 30, 1996 (unaudited) and is qualified in its entirety by reference 
to such financial statements.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-END>                               JUN-30-1996
<CASH>                                           1,464
<SECURITIES>                                         0
<RECEIVABLES>                                    3,035
<ALLOWANCES>                                       642
<INVENTORY>                                      3,879
<CURRENT-ASSETS>                                 8,833
<PP&E>                                           1,438
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                  23,617
<CURRENT-LIABILITIES>                            2,214
<BONDS>                                            404
                                0
                                          0
<COMMON>                                            61
<OTHER-SE>                                      20,938
<TOTAL-LIABILITY-AND-EQUITY>                    23,617
<SALES>                                          6,720
<TOTAL-REVENUES>                                 6,720
<CGS>                                            3,491
<TOTAL-COSTS>                                    3,491
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                  47
<INCOME-PRETAX>                                    206
<INCOME-TAX>                                       412
<INCOME-CONTINUING>                              (206)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     (206)
<EPS-PRIMARY>                                    (.03)
<EPS-DILUTED>                                    (.03)
            

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission